Scarica l'app Stockscreener
0.46
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Citius Pharmaceuticals Inc Azioni (CTXR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
10.41%
1.4938
|
1.6673 | 3.9441 | - | - |
| Cost Of Revenue |
49.55%
0.4918
|
0.3289 | 0.7892 | - | - |
| Gross Profit |
25.14%
1.0019
|
1.3384 | 3.1549 | - | - |
| Operating Expenses |
62.03%
12.73
|
33.53 | 12.17 | 8.4373 | 8.788 |
| Interest Income/Expense |
0.1983
|
- | - | - | - |
| Operating Income/Loss |
63.56%
-11.73
|
-32.19 | -9.0192 | -8.4373 | -8.788 |
| Nonoperating Income/Loss |
107.64%
-0.2945
|
3.8538 | -0.1104 | -0.0421 | -0.1516 |
| Income/Loss From Continuing Operations Before Tax |
57.56%
-12.03
|
-28.34 | -9.1296 | -8.4794 | -8.9396 |
| Income Tax Expense/Benefit, Deferred |
53.57%
-0.1073
|
-0.2312 | 0.2642 | 0.2642 | 0.2642 |
| Income Tax Expense/Benefit |
53.57%
-0.1073
|
-0.2312 | 0.2642 | 0.2642 | 0.2642 |
| Net Income/Loss |
57.60%
-11.92
|
-28.11 | -9.3939 | -8.7436 | -9.2039 |
| Attributable To Noncontrolling Interest |
55.57%
-3.0564
|
-6.8786 | -1.1731 | -0.7844 | -0.414 |
| Basic Average Shares |
16.95%
26.17
|
22.38 | 21.50 | 2.0449 | 11.01 |
| Diluted Average Shares |
16.95%
26.17
|
22.38 | 21.50 | 2.0449 | 11.01 |
| Basic Earnings Per Share |
64.21%
-0.34
|
-0.95 | -0.38 | -0.11 | -0.80 |
| Diluted Earnings Per Share |
64.21%
-0.34
|
-0.95 | -0.38 | -0.11 | -0.80 |
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):